Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2014.12.008
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2015
Authors
Publisher
Elsevier BV